Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Treasury Shares (2021 - 2026)

Treace Medical Concepts filings provide 3 years of Treasury Shares readings, the most recent being $1.2 million for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 321.0% to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 million, a 321.0% increase, with the full-year FY2025 number at $1.2 million, up 321.0% from a year prior.
  • Treasury Shares hit $165513.0 in Q4 2025 for Treace Medical Concepts, up from $141572.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $944175.0 in Q4 2024 to a low of $6578.0 in Q4 2023.
  • Median Treasury Shares over the past 5 years was $19604.0 (2024), compared with a mean of $118492.8.
  • Biggest five-year swings in Treasury Shares: soared 2061.54% in 2024 and later skyrocketed 172.8% in 2025.
  • Treace Medical Concepts' Treasury Shares stood at $13000.0 in 2023, then soared by 2061.54% to $281000.0 in 2024, then soared by 321.0% to $1.2 million in 2025.
  • The last three reported values for Treasury Shares were $1.2 million (Q4 2025), $1.1 million (Q3 2025), and $696000.0 (Q2 2025) per Business Quant data.